Dr. Michael Fasullo is an Associate Professor at State University of New York (SUNY) Polytechnic Institute and an adjunct professor in the School of Public Health, SUNY at Albany. He is a member of the RNA Institute at SUNY Albany. Michael obtained his B.S. from Massachusetts Institute of Technology and a Ph.D. from Stanford University, where he studied molecular biology. A major emphasis of his work has been investigating mechanisms by which cell cycle checkpoints suppress radiation and carcinogen-associated genome instability, a hallmark of carcinogenesis. His current interest is to identify DNA repair genes that confer resistance to food carcinogens. His interest in translational research originated from a project to investigate whether herpes simplex oncolytic viruses could be useful in the treatment of breast cancer. His research has been funded by governmental agencies, including National Cancer Institute, National Institute of Environmental Health Sciences, Department of Defense, and by private granting agencies, including the March of Dimes and Leukemia Research Foundation. He actively collaborates with a broad range of international scientists and has participated in interdisciplinary panels sponsored by the National Academy of Sciences Keck Futures Initiative, including The Genomic Revolution -- Implications for Treatment and Control of Infectious Disease (2006), Nuclear Technologies (2013), and Grand Challenges (2016). He continually advocates for research and pre- and postdoctoral training as a reviewer on National Institutes of Health (NIH), National Science Foundation (NSF) and National Aeronautics and Space Administration (NASA) review panels. Besides an active researcher, his excellence in teaching genetic toxicology and biochemistry was recognized by the undergraduate student association for SUNY Polytechnic Institute in 2021.